Link AIFA

EMA - Nuovi farmaci autorizzati

New medicines and opinions: human

  1. Human medicines European public assessment report (EPAR): Leqembi, Lecanemab, Status: Opinion

    Human medicines European public assessment report (EPAR): Leqembi, Lecanemab, Status: Opinion

  2. Human medicines European public assessment report (EPAR): Kizfizo, temozolomide, Status: Opinion

    Human medicines European public assessment report (EPAR): Kizfizo, temozolomide, Status: Opinion

  3. Human medicines European public assessment report (EPAR): Deqsiga, human normal immunoglobulin, Status: Opinion

    Human medicines European public assessment report (EPAR): Deqsiga, human normal immunoglobulin, Status: Opinion

  4. Human medicines European public assessment report (EPAR): Lynozyfic, linvoseltamab, Status: Opinion

    Human medicines European public assessment report (EPAR): Lynozyfic, linvoseltamab, Status: Opinion

  5. Human medicines European public assessment report (EPAR): Trabectedin Accord, trabectedin, Status: Opinion

    Human medicines European public assessment report (EPAR): Trabectedin Accord, trabectedin, Status: Opinion

Link EMA